144 related articles for article (PubMed ID: 11583308)
1. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.
Vidal C; Spaulding C; Picard F; Schaison F; Melle J; Weber S; Fontenay-Roupie M
Thromb Haemost; 2001 Sep; 86(3):784-90. PubMed ID: 11583308
[TBL] [Abstract][Full Text] [Related]
2. Elevated platelet-derived microparticle levels during unstable angina.
Singh N; Gemmell CH; Daly PA; Yeo EL
Can J Cardiol; 1995 Dec; 11(11):1015-21. PubMed ID: 8542543
[TBL] [Abstract][Full Text] [Related]
3. Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation.
Inoue T; Hikichi Y; Morooka T; Yoshida K; Fujimatsu D; Komoda H; Kameda M; Nonaka M; Sohma R; Hashimoto S; Node K
Platelets; 2006 Sep; 17(6):416-20. PubMed ID: 16973503
[TBL] [Abstract][Full Text] [Related]
4. [Platelets and platelet microparticles glycoprotein IIb/IIIa complex in patients with unstable angina].
Dymicka-Piekarska V; Kemona H; Butkiewicz A; Bychowski J
Pol Merkur Lekarski; 2005 Jan; 18(103):9-12. PubMed ID: 15859538
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
Tomer A
J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
[TBL] [Abstract][Full Text] [Related]
6. [Decreased plasma soluble P-selectin level in coronary sinus after successful coronary angioplasty in patients with unstable angina].
Doi N; Nishio K; Nakatani H; Hayashi T; Miyamoto S; Hashimoto T; Dohi K
J Cardiol; 1999 May; 33(5):251-6. PubMed ID: 10354952
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
[TBL] [Abstract][Full Text] [Related]
9. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion.
Lim YA; Cho SR; Lee WG; Park JS; Kim SW
Platelets; 2008 Aug; 19(5):328-34. PubMed ID: 18791938
[TBL] [Abstract][Full Text] [Related]
10. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
[TBL] [Abstract][Full Text] [Related]
11. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
12. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
13. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Hernández-Antolín R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Macaya C
J Invasive Cardiol; 2004 Jun; 16(6):325-9. PubMed ID: 15156004
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
[TBL] [Abstract][Full Text] [Related]
15. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric assay of platelet glycoprotein receptor numbers in hypercholesterolemia.
Ozsavci D; Yardimci T; Demirel GY; Demiralp E; Uras F; Onder E
Platelets; 2002 Jun; 13(4):223-9. PubMed ID: 12189024
[TBL] [Abstract][Full Text] [Related]
17. Platelet P-selectin and GPIIb/IIIa expression after liver transplantation and resection.
Becker T; Jüttner B; Elsner HA; Meyer zu Vilsendorf A; Bornscheuer A; Nashan B; Brandl M; Klempnauer J; Piepenbrock S; Scheinichen D
Transpl Int; 2004 Sep; 17(8):442-8. PubMed ID: 15316595
[TBL] [Abstract][Full Text] [Related]
18. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Barrera-Ramirez C; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Thromb Res; 2005; 115(1-2):101-8. PubMed ID: 15567460
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone.
Nagy B; Szuk T; Debreceni IB; Kappelmayer J
Platelets; 2010; 21(2):147-51. PubMed ID: 20050761
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
